Anti-Inflammatory Effects of Specific Cyclooxygenase 2,5-Lipoxygenase, and Inducible Nitric Oxide Synthase Inhibitors on Experimental Autoimmune Anterior Uveitis (EAAU)

REFERENCES

• Masferrer J L, Kulkarni P S. Cyclooygenase-2 inhibitors: a new approach to the therapy of ocular inflammation. Ophthalmol Surv 1995; 41: 535–540
   Google Scholar
• Chiou G CY. Review. Effects of nitric oxide on eye diseases and their treatment. J Ocul Pharmacol 2001; 17(2)189–196, [CROSSREF]
   Google Scholar
• Moncada S, Palmer R MJ, Higgs E A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–142, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bito L Z, Camaras C B, Gum G G, Resul B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. The ocular effects of prostaglandins and other eicosanoids, L Z Bito, J Stiernschantz. Alan R Liss, Inc., New York 1989; 349–368
   Google Scholar
• Luckhart S, Rosenberg R. Gene structure and polymorphisim of an invertebrate nitric oxide synthase gene. Gene 1999; 232: 25–34, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Alderton W K, Cooper C E, Knowles R G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593–615, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Weinberg J B. Nitric oxide-2 and cyclooxygenase-2 interaction in inflammation. Immunogenic Res 2001; 22: 319–341, [CROSSREF], [CSA]
   Google Scholar
• Masferrer J L, Zweifel B S, Hauser S, Seibert K, Needleman P. Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and non-ulcerogenic. Proc Natl Acad Sci USA 1994; 91: 3228–3232, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mahlberg K, Uusitalo R, Uusitalo H, Palkama A, Tallberg T. Suppression of experimental autoimmune uveitis in guinea-pigs by inhibition of phospholipase A2. J Ocul Pharmacol 1987; 3(3)199–210, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kulkarni P S, Srinivasan B D. Nonsteroidal anti-inflammatory drugs in ocular inflammatory conditions. Nonsteroidal anti-inflammatory drugs, A J Lewis, D E Furst. Marcel Dekker, Inc., New York, Basel 1987; 107–125
   Google Scholar
• Fleisher L N. Effects of inhibitors of arachidonic acid metabolism on endotoxin-induced ocular inflammation. Curr Eye Res 1988; 7(3)321–327, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kulkarni P S. The role of endogenous eicosanoids in rabbit-intraocular inflammation. J Ocul Pharmacol 1991; 7(3)227–241, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mahlberg K, Uusitalo H, Palkama A, Tallberg T. Correlation between histopathological, clinical and biochemical parameters in S-antigen-induced experimental autoimmune uveitis in guinea-pigs. Exp Eye Res 1987; 45(1)157–167, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mahlberg K, Uusitalo R, Palkama A, Tallberg T. Phospholipase A2, leukotriene C4 and prostaglandin E2 levels in aqueous humor of guinea pigs with experimental S-antigen induced autoimmune uveitis. Curr Eye Res 1987; 6(2)321–335, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Srinivasan B D, Kulkarni P S. The effect of steroidal and nonsteroidal anti-inflammatory agents on corneal reepithelialization. Invest Ophthalmol Vis Sci 1981; 20(5)688–691, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Srinivasan B D, Kulkarni P S. Polymorphonuclear leukocyte response: inhibition following corneal epithelial denudation by steroidal and nonsteroidal anti-inflammatory agents. Arch Ophthalmol 1981; 99: 1085–1089, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kulkarni P S, Bhattacherjee P, Eakins K E, Srinivasan B D. Anti-inflammatory effects of betamethasone phosphate, dexamethasone phosphate and indomethacin on rabbit ocular inflammation induced by bovine serum albumin. Curr Eye Res 1981; 1(1)43–47, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kulkarni P S, Bhattacherjee P, Paterson C. Dexamethasone inhibits the release of rabbit interleukin-1 endotoxin-uveitis model in rabbits. Exp Eye Res 1994; 58: 637–638, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kulkarni P S, Paterson C A. Diclofenac and prednisolone inhibit endotoxin induced uveitis in rabbits. Exp Eye Res 1995; 61: 767–768, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bellot J L, Palmero M, Garcia-Cabanes C, Espi R, Hariton C, Orts A. Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. Inflamm Res 1996; 45(4)203–208, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bellot J L, Palmero M, Alcoriza N, et al. Concomitant treatment with a 5-lipoxygenase inhibitor improves the anti-inflammatory effect of the inhibition of nitric oxide synthase during the early phase of endotoxin-induced uveitis in the rabbit. Ophthalmic Res 1997; 29(4)227–236, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Parks D J, Cheung M K, Chan C C, Roberge F G. The role of nitric oxide in uveitis. Arch Ophthalmol 1994; 112(4)544–546, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Allen J B, McGahan M C, Ferrell J B, Adler K B, Fleisher L N. Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis. Exp Eye Res 1996; 62(1)21–28, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Goureau O, Bellot J, Thillaye B, Courtois Y, de Kozak Y. Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase. J Immunol 1995; 154(12)6518–6523, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Tilton R G, Chang K, Corbett J A, et al. Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci 1994; 35(8)3278–3288, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Matteson D M, Shen D F, Chan C C. Inhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C. J Autoimmun 1999; 13(2)197–204, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Mandai M, Mittag T W, Kogishi J, Iwaki M, Hangai M, Yoshimura N. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1996; 37(5)826–832, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Smith J R, Hart P H, Standfield S D, Coster D J, Wing S J, Williams K A. Apoptosis is a prominent feature of acute anterior uveitis in the Fischer 344 rat. Br J Ophthalmol 2000; 84: 205–211, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Chen F, Pararajasegaram G, Sevanian A, Rao N A. Treatment of S antigen uveoretinitis with lipoxygenase and cyclooxygenase inhibitors. Ophthalmic Res 1991; 23(2)84–91, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Broekhuyse R M, Kuhlman E D, Winkens H J, Van Vugt A H. Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble, intrinsic protein fraction of the retina pigment epithelium. Exp Eye Res. 1991; 52: 465–474, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nussenblatt R B, Whitcup S M, Palestine A G. Uveitis: fundamentals and clinical practice. Mosby, St. Louis, MO 1996; 413 pp.
   Google Scholar
• Bora N S, Kim M C, Kabeer N H, Simpson S C, Tandhasetti M T, Cirrito T P, Kaplan A D, Kaplan H J. Experimental autoimmune anterior uveitis (EAAU): induction with melanin associated antigen from the iris and ciliary body. Invest. Ophthalmol Vis Sci. 1995; 36: 1056–1066, [CSA]
   PubMedGoogle Scholar
• Kim M C, Kabeer N H, Tandhasetti M T, Kaplan H J, Bora N S. Immunohistochemical studies in melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res. 1995; 4: 703–710
   Google Scholar
• Bora N S, Woon M D, Tandhasetti M T, Cirrito T P, Kaplan H J. Induction of experimental autoimmune anterior uveitis by a self-antigen: melanin complex without adjuvant. Invest Ophthalmol Vis Sci. 1997; 38: 2171–2175, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Gierse J K, McDonald J J, Hauser S D, Rangwala S H, Koboldot C M, Seibert K. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2(COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem 1996; 271: 15810–15814, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994; 91: 12013–12017, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jaramillo A, Bhattacherjee P, Sonnenfeld G, Paterson C A. Modulation of immune responses by cyclo-oxygenase inhibitors during intraocular inflammation. Curr Eye Res 1992; 11(6)571–579, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sand B B, Krough E. Topical indomethacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroid versus steroid anti-inflamatory treatment. Acta Ophthalmol 1991; 69: 145–148
   Google Scholar
• Crooks S W, Stockley R A. Leukotriene B4. Int J Biochem Cell Biol 1998; 30: 173–178, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Smith J R, Hart P H, Coster D J, Williams K A. Mice deficient in tumor necrosis factor receptors p55 and p75, interlukin-4, or inducible nitric oxide synthase are susceptible to endotoxin induced uveitis. Invest Ophthalmol Vis Sci 1998; 39: 658–661, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar